• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TISSUE SCIENCE LABORATORIES PELVILACE BIOURETHRAL SUPPORT SYSTEM; PAG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TISSUE SCIENCE LABORATORIES PELVILACE BIOURETHRAL SUPPORT SYSTEM; PAG Back to Search Results
Catalog Number 482150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Micturition Urgency (1871); Incontinence (1928); Injury (2348)
Event Type  Injury  
Event Description
The patient's attorney alleged a deficiency against the device.Per additional information received, the patient has experienced pain, urinary problems, bowel problems, recurrence, dyspareunia (painful sexual intercourse), vaginal scarring, wound abscess, nausea, suprapubic wound hematoma, suprapubic tenderness and pressure, right groin pain, urinary incontinence, pelvic pain, urinary retention, urinary urgency, overactive bladder dysfunction, urethral obstruction, bleeding, chest pain, retractable urge urinary incontinence, nocturia, vaginal vault prolapse, cystocele, rectocele, enterocele and urinary frequency.
 
Manufacturer Narrative
The sample was not returned.The lot number is unknown; therefore, the device history record could not be reviewed.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the potential complications: complications associated with the proper implantation of the pelvilace biourethral support system may include, but are not limited to: postoperative hematoma.Temporary urinary retention, bladder outlet obstruction, and voiding difficulties associated with over-correction/too much tension placed on the implant.Perforations or lacerations of vessels, nerves, bladder or bowel, which may occur during needle passage.(b)(4).The total number of events for product classification code pag is 3.Qty 2- pelvilace biourethral support system 2 needle introducers, 1 disposable handle, 4 tissue connectors, 1.5cm x 50cm porcine accellular collagen matrix sling; qty 1- pelvilace to biourethral support system needle and implant hook needle 50cm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELVILACE BIOURETHRAL SUPPORT SYSTEM
Type of Device
PAG
Manufacturer (Section D)
TISSUE SCIENCE LABORATORIES
astley lane industrial estate
unit 1
swillington, leeds, LS26 8XT
UK  LS26 8XT
Manufacturer (Section G)
TISSUE SCIENCE LABORATORIES
astley lane industrial estate
unit 1
swillington, leeds, LS26 8XT
UK   LS26 8XT
Manufacturer Contact
christy lewis
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key4469971
MDR Text Key15317723
Report Number1018233-2015-00024
Device Sequence Number1
Product Code PAG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K031295
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Attorney
Type of Report Initial
Report Date 10/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number482150
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Event Location Hospital
Initial Date Manufacturer Received 10/20/2014
Initial Date FDA Received01/30/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
-
-